May 30 2013
Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.
The award is administered by Pharmacy Quality Alliance (PQA), an organization dedicated to improving patient health by championing clear performance measures for medication management, and recognizes those organizations that foster exceptional pharmacy quality.
"We are honored to be recognized by PQA for our commitment to continuously enhancing the quality of care in the Medicare arena," said Mark Thierer , Chairman and Chief Executive Officer of Catamaran. "By leveraging our resources, skill, and scale, Catamaran has achieved powerful results in improving health outcomes and reducing costs, all with a laser-sharp focus on patient safety."
PQA's recognition program for prescription drug plans recognizes Medicare prescription drug plans (both MA-PD and PDP) that have demonstrated outstanding performance in medication-related quality as determined through the use of publicly-available performance data for Medicare Part D.
"Catamaran Corporation has achieved industry-leading safety scores in the care of its Medicare members, meeting PQA's standards of excellence for this year's Quality Recognition Award," said Laura Cranston , PQA's Executive Director. "Catamaran serves as a model for the high outcomes that are possible when innovation and commitment come together across an organization."
The award was formally presented at PQA's annual meeting and luncheon on May 29, 2013. This is the third year the consensus-based, multi-stakeholder organization provided this unique recognition to top healthcare providers administrating Medicare prescription services across the nation.
Research reveals Medicare's inadequate payments for lifesaving stroke procedures